QT
TEVA icon

Quantbot Technologies’s Teva Pharmaceuticals TEVA Stock Holding History

Quantbot Technologies’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-145,941
Closed -$2.45M – 2098
2025
Q2 		$2.45M Buy
145,941
+100,187
+219% +$1.62M 0.06% 455
2025
Q1 		$703K Sell
45,754
-180,520
-80% -$3.22M 0.02% 786
2024
Q4 		$4.99M Buy
+226,274
New +$4.12M 0.18% 155
2023
Q3 		– Sell
-316,265
Closed -$2.38M – 1953
2023
Q2 		$2.38M Buy
316,265
+285,891
+941% +$2.32M 0.16% 188
2023
Q1 		$269K Sell
30,374
-56,137
-65% -$555K 0.02% 801
2022
Q4 		$789K Buy
+86,511
New +$755K 0.06% 438
2022
Q3 		– Sell
-6,420
Closed -$48K – 2087
2022
Q2 		$48K Sell
6,420
-5,351
-45% -$46.6K ﹤0.01% 1309
2022
Q1 		$110K Buy
+11,771
New +$98.2K 0.01% 1021
2021
Q2 		– Sell
-16,815
Closed -$194K – 1858
2021
Q1 		$194K Sell
16,815
-1,495
-8% -$17.1K 0.02% 726
2020
Q4 		$176K Buy
18,310
+7,238
+65% +$69.3K 0.02% 636
2020
Q3 		$99K Buy
11,072
+7,660
+225% +$81K 0.01% 728
2020
Q2 		$42K Sell
3,412
-2,488
-42% -$28.1K 0.01% 742
2020
Q1 		$52K Buy
+5,900
New +$60.4K 0.03% 428
2019
Q4 		– Sell
-22,108
Closed -$152K – 1580
2019
Q3 		$152K Sell
22,108
-58,699
-73% -$450K 0.02% 749
2019
Q2 		$745K Buy
+80,807
New +$974K 0.07% 302
2017
Q4 		– Sell
-54,977
Closed -$967K – 1474
2017
Q3 		$967K Sell
54,977
-66,845
-55% -$1.5M 0.09% 303
2017
Q2 		$4.05M Buy
121,822
+15,219
+14% +$471K 0.38% 56
2017
Q1 		$3.42M Buy
+106,603
New +$3.64M 0.36% 57
2016
Q4 		– Sell
-103,544
Closed -$4.76M – 1344
2016
Q3 		$4.76M Buy
103,544
+14,486
+16% +$756K 0.53% 36
2016
Q2 		$4.47M Sell
89,058
-15,058
-14% -$802K 0.48% 48
2016
Q1 		$5.57M Buy
+104,116
New +$6.11M 0.89% 13
2015
Q4 		– Sell
-138,008
Closed -$7.79M – 1356
2015
Q3 		$7.79M Buy
+138,008
New +$8.95M 1.36% 5
2015
Q1 		– Sell
-23,657
Closed -$1.36M – 1342
2014
Q4 		$1.36M Buy
23,657
+7,430
+46% +$414K 0.44% 37
2014
Q3 		$872K Buy
+16,227
New +$860K 0.12% 263
2014
Q1 		– Sell
-18,889
Closed -$757K – 1335
2013
Q4 		$757K Buy
+18,889
New +$744K 0.37% 69

Other funds holding TEVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

Quantbot Technologies's TEVA Position: Q3 2025 in Review

Quantbot Technologies sold out of Teva Pharmaceuticals (TEVA) in Q3 2025, closing a stake of 145,941 shares — an estimated $2.45M sold.

Quantbot Technologies first reported a position in TEVA in Q4 2013 and held it in 25 quarters. The position peaked at $7.79M in Q3 2015. 550 funds tracked by Wall St. Rank hold TEVA as of Q3 2025.

  • Quantbot Technologies reported no remaining Teva Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Quantbot Technologies sold 145,941 Teva Pharmaceuticals shares in Q3 2025, an estimated $2.45M.
  • Quantbot Technologies first reported a position in Teva Pharmaceuticals in Q4 2013 and held it in 25 quarters.
  • Quantbot Technologies's Teva Pharmaceuticals position peaked at $7.79M in Q3 2015.
  • 550 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2025.

Based on Quantbot Technologies's 13F filing for Q3 2025, filed 12 Nov 2025.